Other News

Surefire Medical Names Former Novelion CEO as New Leader

DENVER–(BUSINESS WIRE)– Surefire Medical (Surefire) today announced the appointment of Mary T. Szela as its CEO, President, and a member of the company’s Board of Directors. Szela brings nearly 30 years of progressive leadership experience to Surefire building global billion-dollar brands, advancing pipeline products in the biotechnology, medical products, and pharmaceutical industries, […]

Cardiome Announces Expanded Label for Aggrastat in China Including New STEMI Indication and High Dose Bolus Regimen

VANCOUVER, Jan. 23, 2018 /PRNewswire/ – Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that the Chinese Center for Drug Evaluation (CDE) has approved an expansion of the indications for Aggrastat (tirofiban hydrochloride) to now, in addition to acute coronary syndromes […]

Baylis Medical Embraces Advanced Manufacturing With Opening of State-of-the-Art Lab

TORONTO, Jan. 22, 2018 /PRNewswire/ – Baylis Medical, a global medical device company, has taken the next pivotal step in its global expansion strategy with the official opening of a new state-of-the-art laboratory in Mississauga, Ontario. The new extrusion lab will allow the company to expand its capabilities and capacity to design, […]

HeartSciences Showcases High Sensitivity ECG at 2018 Arab Health Meeting

SOUTHLAKE, Texas–(BUSINESS WIRE)– HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 Arab Health show at the Dubai International Convention and Exhibition Centre in Dubai, UAE, 29 January through 01 February, 2018. HeartSciences is advancing the field of electrocardiology in combining […]

Neovasc Names Former BeneChill CEO as New Leader

VANCOUVER, Jan. 22, 2018 /PRNewswire/ – Neovasc (“Neovasc” or the “Company“) (Nasdaq, TSX: NVCN), a front-runner in minimally invasive transcatheter mitral valve technologies today announced that its board of directors (the “Board”) has appointed Fred A. Colen as president and chief executive officer effective immediately. This leadership transition is a key element […]

FDA Green Lights Surmodics’ Telemark Coronary/Peripheral Support Microcatheter

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)– SurModics (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced it has received Food and Drug Administration (FDA) 510(k) clearance for its Telemark™ .014” coronary and peripheral support microcatheter. The Company is making this product available for U.S. distribution in the […]

Baxter Announces U.S. FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International, Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today announced the FDA approval of Bivalirudin in 0.9 percent Sodium Chloride Injection (bivalirudin). Bivalirudin is a specific and direct thrombin inhibitor indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI), a common […]

Non-Culprit Lesions Cause 2x More Subsequent MIs than PCI’d Lesions

by Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) A new study published in the Journal of the American Heart Association shows that AMIs following a percutaneous coronary intervention (PCI) is twice as likely to originate from untreated lesions versus previous stented lesions. Interesting since this information seems to differ from previous studies such as PROSPECT […]

Edwards Lifesciences To Host Earnings Conference Call On February 1, 2018

IRVINE, Calif., Jan. 18, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended December 31, 2017 after the market closes on Thursday, February 1, 2018, and will host a conference call at 5:00 p.m. […]